Biodesix, Inc.
BDSX
$8.45
$0.313.81%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.72M | -11.47M | -11.10M | -8.25M | -10.26M |
| Total Depreciation and Amortization | 1.41M | 1.44M | 1.44M | 1.45M | 1.49M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.37M | 1.29M | 1.80M | 2.05M | 1.76M |
| Change in Net Operating Assets | -2.94M | 2.17M | -739.00K | 658.00K | -3.67M |
| Cash from Operations | -8.88M | -6.57M | -8.60M | -4.10M | -10.67M |
| Capital Expenditure | -48.00K | -51.00K | -74.00K | -839.00K | -231.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -19.00K | -44.00K | -63.00K | -45.00K | -55.00K |
| Cash from Investing | -67.00K | -95.00K | -137.00K | -884.00K | -286.00K |
| Total Debt Issued | 0.00 | 10.00M | -- | -- | -- |
| Total Debt Repaid | -4.00K | -5.00K | -7.00K | -13.00K | -13.00K |
| Issuance of Common Stock | 5.18M | 0.00 | 313.00K | 7.00K | 354.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -358.00K | -206.00K | -209.00K | -175.00K | -197.00K |
| Cash from Financing | 4.82M | 9.79M | 97.00K | -181.00K | 144.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.12M | 3.13M | -8.64M | -5.16M | -10.81M |